Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.

Grzegorz CharlińskiNorbert GrząśkoŁukasz BołkunWaldemar SawickiEdyta PaczkowskaAgnieszka Druzd-SitekLidia Usnarska-ZubkiewiczAleksandra ButrymElżbieta WiaterPiotr BoguradzkiBożena BudziszewskaMałgorzata WojciechowskaMonika Mordak-DomagałaArtur Jurczyszyn

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Patients with MM treated with IMiDs are highly adherent to treatment. With time from the beginning of treatment, patients need more attention and motivation to adhere to the therapy rules.

Keyphrases

newly diagnosed
multiple myeloma
end stage renal disease
ejection fraction
chronic kidney disease
mental health
stem cells
patient reported outcomes
mesenchymal stem cells
skeletal muscle
bone marrow
weight loss
patient reported
clinical evaluation